View ValuationDKSH Holding 향후 성장Future 기준 점검 1/6DKSH Holding (는) 각각 연간 9.2% 및 2.1% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 9.6% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 14.3% 로 예상됩니다.핵심 정보9.2%이익 성장률9.61%EPS 성장률Trade Distributors 이익 성장13.7%매출 성장률2.1%향후 자기자본이익률14.27%애널리스트 커버리지Good마지막 업데이트08 May 2026최근 향후 성장 업데이트Price Target Changed • Nov 21Price target decreased by 7.4% to CHF73.90Down from CHF79.80, the current price target is an average from 6 analysts. New target price is 31% above last closing price of CHF56.50. Stock is down 22% over the past year. The company is forecast to post earnings per share of CHF3.16 for next year compared to CHF3.09 last year.Price Target Changed • May 12Price target decreased by 12% to CHF70.83Down from CHF80.83, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of CHF69.85. Stock is down 14% over the past year. The company is forecast to post earnings per share of CHF3.34 for next year compared to CHF3.09 last year.공지 • Jul 15DKSH Provides Earnings Guidance for the Year 2022DKSH provided earnings guidance for the year 2022. The company expects EBIT growth in 2022.모든 업데이트 보기Recent updates공지 • Mar 30+ 1 more updateDKSH Holding AG Approves Board ElectionsDKSH Holding AG announced at annual general meeting held on March 27, 2026, the shareholders elected Corine Tap, and Julie von Wedel-Keller as new members of the Board of Directors.Upcoming Dividend • Mar 24Upcoming dividend of CHF2.50 per shareEligible shareholders must have bought the stock before 31 March 2026. Payment date: 02 April 2026. Payout ratio is on the higher end at 80%, however this is supported by cash flows. Trailing yield: 4.3%. Within top quartile of Swiss dividend payers (3.6%). Higher than average of industry peers (2.6%).공지 • Mar 23DKSH Holding AG(SWX:DKSH) dropped from FTSE All-World Index (USD)DKSH Holding AG(SWX:DKSH) dropped from FTSE All-World Index (USD)공지 • Mar 06DKSH Holding AG, Annual General Meeting, Mar 27, 2026DKSH Holding AG, Annual General Meeting, Mar 27, 2026, at 10:00 W. Europe Standard Time.Reported Earnings • Feb 19Full year 2025 earnings released: EPS: CHF3.12 (vs CHF3.31 in FY 2024)Full year 2025 results: EPS: CHF3.12 (down from CHF3.31 in FY 2024). Revenue: CHF11.1b (flat on FY 2024). Net income: CHF202.9m (down 5.5% from FY 2024). Profit margin: 1.8% (down from 1.9% in FY 2024). Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Trade Distributors industry in Europe. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.공지 • Feb 18DKSH Holding AG announces Annual dividend, payable on April 02, 2026DKSH Holding AG announced Annual dividend of CHF 2.5000 per share payable on April 02, 2026, ex-date on March 31, 2026 and record date on April 01, 2026.내러티브 업데이트 • Feb 11DKSH: Potential Swixx Acquisition Will Support Undervalued Healthcare Distribution PlatformAnalysts have maintained their price target for DKSH Holding at around CHF 72.57. This suggests only very small adjustments in assumptions for the discount rate, long-term revenue growth, profit margin and future P/E to reflect updated risk and earnings expectations.내러티브 업데이트 • Jan 27DKSH: Future Healthcare And Consumer Distribution Deals Will Support Undervalued SharesAnalysts have nudged their price target for DKSH Holding slightly higher, with fair value rising from CHF 72.17 to about CHF 72.57. This reflects small adjustments to assumptions around the discount rate, modestly stronger revenue growth, a marginally softer profit margin and a slightly higher future P/E multiple.공지 • Jan 16DKSH Management AG Announces Retirement of Thomas Sul from the Role as Co-Head and Member of the Executive CommitteeDKSH Management AG announced that Thomas Sul, Co-Head of the Business Unit Performance Materials and Member of the Executive Committee, has decided to gradually scale down his activities as he eases into retirement and has stepped down from his role as Co-Head and Member of the Executive Committee. Natale Capri, who has served as Co-Head for over ten years, assumes full responsibility as Head of the Business Unit Performance Materials and will remain a Member of the Executive Committee. After nearly 30 years at DKSH, Thomas Sul leaves behind a remarkable legacy. Under his co-leadership, Performance Materials has achieved significant milestones, including driving globalization, strengthening business development, realizing multiple acquisitions, and doubling operating profit. Thomas will continue to contribute his expertise in a strategic capacity after scaling down his activities in the first quarter of 2026.내러티브 업데이트 • Jan 12DKSH: Future Asia Distribution Deals Will Support Undervalued Share PriceAnalysts have trimmed their price target on DKSH Holding to about CHF 72, down from roughly CHF 74, citing updated assumptions for fair value, discount rate, revenue growth, profit margins and a slightly higher future P/E multiple. What's in the News DKSH is reported to be among potential bidders for Swiss pharmaceutical distributor Swixx Biopharma, with the target company said to be valued in a range of €1.5b to €2b.공지 • Dec 19DKSH Holding AG (SWX:DKSH) agreed to acquire Biomedic Science Material Joint Stock Company.DKSH Holding AG (SWX:DKSH) agreed to acquire Biomedic Science Material Joint Stock Company on December 17, 2025. For the period ending December 31, 2024, Biomedic Science Material Joint Stock Company reported total revenue of CHF 12 million. The expected completion of the transaction is January 1, 2026 to March 31, 2026.분석 기사 • Dec 15DKSH Holding (VTX:DKSH) Has More To Do To Multiply In Value Going ForwardIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...공지 • Nov 22DKSH Management Ltd. Announces Executive ChangesDKSH Management Ltd. announced the appointment of Patrik Grande as new Head Business Unit Healthcare as of January 2026. Currently Vice President, Commercial Outsourcing & Cluster Head APAC, he will be a member of DKSH's Executive Committee, report to CEO Stefan P. Butz, and will relocate from Bangkok to Singapore within the next year. Patrik Grande follows Bijay Singh who will begin his retirement on March 31, 2026, after eleven years at DKSH. Patrik Grande is a well-seasoned and accomplished leader with more than 20 years of experience in the global pharmaceutical industry. He joined DKSH in 2022 as Vice President, Business Unit Healthcare Thailand, following a successful two-decade career at Novartis. During his time at Novartis, he held increasingly senior leadership roles across multiple markets, including South Korea, Malaysia, the United Kingdom, Switzerland, Russia, and Spain. Since joining DKSH, Patrik has revitalized the Healthcare business in Thailand and delivered growth. In his role as Vice President, Commercial Outsourcing & Cluster Head APAC, he strengthened the strategic commercial outsourcing pillar, expanded the robust regional capabilities, delivering growth and driving strategic progress across the region. A Spanish citizen, Patrik holds a Master's degree in Business Administration from IESE Business School. Bijay Singh leaves behind an outstanding legacy after eleven years at DKSH, including nearly nine years as Head Business Unit Healthcare and Member of the Executive Committee. Bijay Singh joined DKSH as Vice President, Global Business Development for Business Unit Healthcare in 2015. His tenure was marked by significant achievements such as building robust commercial outsourcing capabilities, driving strategic M&As, expanding the Healthcare business into new markets such as Australia, the Philippines, and South Korea, and fostering a strong talent pipeline.공지 • Nov 18DKSH Reportedly to Weigh Bid for Pharma Distributor Swixx BiopharmaDKSH Holding AG (SWX:DKSH) is among the companies exploring a potential acquisition of Swiss pharmaceutical distributor Swixx Biopharma (Swixx Biopharma SA), Bloomberg News reported on November 16, 2025, citing people familiar with the matter. Private-equity firms SK Capital Partners (SK Capital Partners, LP) and Lone Star (Lone Star Americas Acquisitions, Inc.) are also said to be evaluating bids. The sources indicated that Swixx could fetch EUR 1.5 billion to EUR 2 billion ($1.7 billion to $2.2 billion), though talks are ongoing and may not lead to a deal. Additional bidders could still join the process. Swixx, jointly owned by HBM Healthcare Investments and members of its management team, specializes in helping drugmakers navigate distribution in smaller and more regulated markets. The company operates in 44 countries and recorded EUR 900 million in 2023 revenue, according to its website. Zurich-based DKSH, valued at roughly CHF 3.5 billion, runs a similar distribution and marketing platform spanning healthcare, consumer goods, technology and industrial materials. Representatives for DKSH, Lone Star and HBM declined to comment to Bloomberg News. SK Capital did not respond to a request for comment, and Swixx could not be reached.분석 기사 • Nov 16The Price Is Right For DKSH Holding AG (VTX:DKSH)With a median price-to-earnings (or "P/E") ratio of close to 20x in Switzerland, you could be forgiven for feeling...내러티브 업데이트 • Sep 06Asia Pacific Expansion And Digitalization Will Fuel Sustainable SuccessThe consensus analyst price target for DKSH Holding has been revised downward, reflecting modest declines in both revenue growth forecasts and the future P/E ratio, resulting in a new fair value of CHF74.00. What's in the News DKSH Consumer Goods has partnered with Nextfood Global to launch premium breakfast cereals and freeze-dried fruit snacks in Singapore, targeting health-conscious, urban consumers.분석 기사 • Aug 26DKSH Holding (VTX:DKSH) Hasn't Managed To Accelerate Its ReturnsDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...분석 기사 • Aug 08DKSH Holding (VTX:DKSH) Seems To Use Debt Quite SensiblyThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Reported Earnings • Jul 20First half 2025 earnings: EPS misses analyst expectationsFirst half 2025 results: EPS: CHF1.41 (down from CHF1.71 in 1H 2024). Revenue: CHF5.53b (up 1.5% from 1H 2024). Net income: CHF91.8m (down 17% from 1H 2024). Profit margin: 1.7% (down from 2.0% in 1H 2024). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 18%. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Trade Distributors industry in Europe. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 9% per year.공지 • Jun 20+ 1 more updateDKSH Holding AG to Report Fiscal Year 2025 Results on Feb 17, 2026DKSH Holding AG announced that they will report fiscal year 2025 results on Feb 17, 2026분석 기사 • Jun 17Earnings Tell The Story For DKSH Holding AG (VTX:DKSH)It's not a stretch to say that DKSH Holding AG's ( VTX:DKSH ) price-to-earnings (or "P/E") ratio of 19.3x right now...공지 • May 21DKSH Holding AG (SWX:DKSH) signed an agreement to acquire A.P.N Plastics Pty Ltd.DKSH Holding AG (SWX:DKSH) signed an agreement to acquire A.P.N Plastics Pty Ltd on May 20, 2025. DKSH will acquire the entire business and fully integrate the company into its existing operations. APN Plastics generates annual net sales of more than CHF 25 million. The transaction is subject to customary closing conditions. The closing of the transaction is expected during the second quarter of 2025.분석 기사 • May 16DKSH Holding's (VTX:DKSH) Returns Have Hit A WallIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...Valuation Update With 7 Day Price Move • Apr 04Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CHF58.70, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 15x in the Trade Distributors industry in Europe. Total loss to shareholders of 21% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CHF94.58 per share.공지 • Mar 29DKSH Holding AG Announces Board ChangesDKSH Holding AG at its Annual General Meeting held on 27 March 2025, announced Dr. Hans Christoph Tanner did not stand for reelection. Suwannee Ratthayabandith was elected as a new member of the Board of Directors.Upcoming Dividend • Mar 24Upcoming dividend of CHF2.35 per shareEligible shareholders must have bought the stock before 31 March 2025. Payment date: 02 April 2025. Payout ratio is a comfortable 71% and this is well supported by cash flows. Trailing yield: 3.2%. Lower than top quartile of Swiss dividend payers (4.0%). Higher than average of industry peers (2.4%).공지 • Mar 07DKSH Holding AG to Report First Half, 2025 Results on Jul 17, 2025DKSH Holding AG announced that they will report first half, 2025 results on Jul 17, 2025공지 • Feb 28DKSH Holding AG, Annual General Meeting, Mar 27, 2025DKSH Holding AG, Annual General Meeting, Mar 27, 2025, at 10:00 W. Europe Standard Time.새 내러티브 • Feb 23New Partnerships With Alcon And Ichitan Will Expand Market Presence And Efficiency Strategic priorities and M&A partnerships are set to enhance market position and drive significant revenue and earnings growth. Reported Earnings • Feb 13Full year 2024 earnings released: EPS: CHF3.31 (vs CHF2.80 in FY 2023)Full year 2024 results: EPS: CHF3.31 (up from CHF2.80 in FY 2023). Revenue: CHF11.1b (flat on FY 2023). Net income: CHF214.8m (up 18% from FY 2023). Profit margin: 1.9% (up from 1.6% in FY 2023). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Trade Distributors industry in Europe. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 1% per year.공지 • Jan 07DKSH Holding AG (SWX:DKSH) acquired Clmo Technology Sdn. Bhd.DKSH Holding AG (SWX:DKSH) acquired Clmo Technology Sdn. Bhd. on January 7, 2025. Clmo Technology Sdn. Bhd.'s management team will join DKSH Holding AG’s business unit technology. DKSH Holding AG (SWX:DKSH) completed the acquisition of Clmo Technology Sdn. Bhd. on January 7, 2025.공지 • Dec 06DKSH Holding AG to Report Fiscal Year 2024 Results on Feb 12, 2025DKSH Holding AG announced that they will report fiscal year 2024 results on Feb 12, 2025공지 • Nov 13DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare DistributionDKSH Healthcare Business Unit, in partnership with Euris, is introducing ConnectPlus, a data-driven Customer Relationship Management (CRM) and Multi-Channel Engagement (MCE) platform aimed at transforming healthcare distribution across the Asia Pacific region. Designed to enhance productivity and operational efficiency, this platform provides a 360° view of healthcare professionals, streamlines MCE, and strengthens DKSH Healthcare's ability to tailor interactions and marketing strategies. The roll-out will start in Thailand in January 2025. With this new platform DKSH Healthcare reinforces its dedication to commercial excellence by enlarging possibilities and improving interactions with clients, customers, and patients. The introduction of ConnectPlus underscores DKSH Healthcare's commitment to harnessing digital solutions that orchestrate and maximize impact of both client and patient interactions, while upholding a high standard of operational excellence. ConnectPlus empowers DKSH to tap into the vast potential provided by the global healthcare big data market by delivering precise, targeted engagement strategies that cater to the unique needs of healthcare professionals, clients, and patients across the region. Furthermore, ConnectPlus is strategically designed to leverage the existing preference of face-to-face sales visits, by orchestrating personalized digital touchpoints, based on data driven insights, to prepare and enhance in-person interactions. The platform's ability to blend in-person and digital strategies is essential for maximizing outreach and driving meaningful engagement. By integrating advanced AI and analytics, ConnectPlus not only streamlines communication and marketing efforts but also personalizes interactions based on real-time data, ensuring relevance and impact. This marks a crucial milestone in DKSH Healthcare's journey towards fully integrating digital innovation into its operations, reinforcing its leadership in driving agility and efficiency within the rapidly evolving healthcare landscape.Reported Earnings • Jul 18First half 2024 earnings released: EPS: CHF1.71 (vs CHF1.59 in 1H 2023)First half 2024 results: EPS: CHF1.71 (up from CHF1.59 in 1H 2023). Revenue: CHF5.45b (down 3.3% from 1H 2023). Net income: CHF111.2m (up 7.5% from 1H 2023). Profit margin: 2.0% (up from 1.8% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 3.9% p.a. on average during the next 3 years, compared to a 2.5% growth forecast for the Trade Distributors industry in Europe. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 4% per year.Upcoming Dividend • Mar 21Upcoming dividend of CHF2.25 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 03 April 2024. Payout ratio is on the higher end at 80%, however this is supported by cash flows. Trailing yield: 3.6%. Lower than top quartile of Swiss dividend payers (4.1%). Higher than average of industry peers (2.2%).Declared Dividend • Feb 29Dividend increased to CHF2.25Dividend of CHF2.25 is 4.7% higher than last year. Ex-date: 28th March 2024 Payment date: 3rd April 2024 Dividend yield will be 3.5%, which is higher than the industry average of 2.3%. Sustainability & Growth Dividend is covered by both earnings (80% earnings payout ratio) and cash flows (43% cash payout ratio). The dividend has increased by an average of 11% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 30% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Feb 18Full year 2023 earnings: EPS misses analyst expectationsFull year 2023 results: EPS: CHF2.80 (down from CHF3.10 in FY 2022). Revenue: CHF11.1b (down 2.2% from FY 2022). Net income: CHF182.0m (down 9.5% from FY 2022). Profit margin: 1.6% (down from 1.8% in FY 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 8.3%. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 2.8% growth forecast for the Trade Distributors industry in Europe. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has fallen by 2% per year.공지 • Dec 23+ 2 more updatesDKSH Holding AG to Report First Half, 2024 Results on Jul 16, 2024DKSH Holding AG announced that they will report first half, 2024 results on Jul 16, 2024Price Target Changed • Nov 21Price target decreased by 7.4% to CHF73.90Down from CHF79.80, the current price target is an average from 6 analysts. New target price is 31% above last closing price of CHF56.50. Stock is down 22% over the past year. The company is forecast to post earnings per share of CHF3.16 for next year compared to CHF3.09 last year.공지 • Sep 19DKSH Holding AG (SWX:DKSH) agreed to acquire CS Company Ltd.DKSH Holding AG (SWX:DKSH) agreed to acquire CS Company Ltd on September 18, 2023. CS Company generates net sales of over CHF 35 million. The deal is expected to close in the fourth quarter, subject to certain conditions.Reported Earnings • Jul 20First half 2023 earnings released: EPS: CHF1.59 (vs CHF1.58 in 1H 2022)First half 2023 results: EPS: CHF1.59 (up from CHF1.58 in 1H 2022). Revenue: CHF5.63b (flat on 1H 2022). Net income: CHF103.4m (flat on 1H 2022). Profit margin: 1.8% (in line with 1H 2022). Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Professional Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Buying Opportunity • Jun 22Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 8.1%. The fair value is estimated to be CHF83.15, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%. For the next 3 years, revenue is forecast to grow by 3.6% per annum. Earnings is also forecast to grow by 8.7% per annum over the same time period.공지 • May 31DKSH Holding AG to Report First Half, 2023 Results on Jul 18, 2023DKSH Holding AG announced that they will report first half, 2023 results on Jul 18, 2023Buying Opportunity • May 17Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 15%. The fair value is estimated to be CHF84.63, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%. For the next 3 years, revenue is forecast to grow by 3.6% per annum. Earnings is also forecast to grow by 8.7% per annum over the same time period.Price Target Changed • May 12Price target decreased by 12% to CHF70.83Down from CHF80.83, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of CHF69.85. Stock is down 14% over the past year. The company is forecast to post earnings per share of CHF3.34 for next year compared to CHF3.09 last year.공지 • May 11DKSH Appoints Chris Ritchie as New Head Business Unit Consumer GoodsDKSH announced the appointment of Chris Ritchie as new Head Business Unit Consumer Goods as of mid-August 2023. Based in Singapore, he will be a member of DKSH's Executive Committee and report to CEO Stefan P. Butz. Chris Ritchie follows Terry Seremetis, who, after four years, decided to pursue his career opportunities outside of DKSH as announced on January 3, 2023. Chris Ritchie has 28 years of experience in the consumer goods industry. For the last four years, he was Chief Global Business Officer of Sazerac, a leading privately held American spirit company, where he oversaw operations in Asia Pacific and Europe. From 2016 to 2019, he was General Manager at Reckitt Benckiser, responsible for the growth market Philippines. Prior to that, from 2007 to 2016, he held various General Manager and Director positions at SABMiller in Asia, Europe, and Americas, including Managing Director of SABMiller Vietnam. From 1995 to 2006, he held regional and global marketing roles at P&G. Throughout his career, Chris has driven growth, route-to-market, and built strong teams, especially in developing markets. A Canadian citizen,Chris (50 years) holds a Bachelor's degree in Economics from Queen's University in Kingston, Canada.Buying Opportunity • Mar 18Now 21% undervaluedOver the last 90 days, the stock is up 3.3%. The fair value is estimated to be CHF92.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%. For the next 3 years, revenue is forecast to grow by 3.9% per annum. Earnings is also forecast to grow by 8.9% per annum over the same time period.Upcoming Dividend • Mar 13Upcoming dividend of CHF2.15 per share at 2.8% yieldEligible shareholders must have bought the stock before 20 March 2023. Payment date: 22 March 2023. Payout ratio is a comfortable 69% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of Swiss dividend payers (4.2%). In line with average of industry peers (2.6%).Buying Opportunity • Mar 01Now 20% undervaluedOver the last 90 days, the stock is up 7.8%. The fair value is estimated to be CHF95.74, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%. For the next 3 years, revenue is forecast to grow by 3.9% per annum. Earnings is also forecast to grow by 8.8% per annum over the same time period.Buying Opportunity • Feb 10Now 19% undervaluedOver the last 90 days, the stock is up 14%. The fair value is estimated to be CHF98.76, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%. For the next 3 years, revenue is forecast to grow by 4.1% per annum. Earnings is also forecast to grow by 8.7% per annum over the same time period.Reported Earnings • Feb 10Full year 2022 earnings released: EPS: CHF3.09 (vs CHF3.45 in FY 2021)Full year 2022 results: EPS: CHF3.09 (down from CHF3.45 in FY 2021). Revenue: CHF11.4b (up 2.1% from FY 2021). Net income: CHF201.1m (down 10% from FY 2021). Profit margin: 1.8% (down from 2.0% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Professional Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 10% per year.공지 • Dec 31Pascal Raffy agreed to acquire 25% stake in Bovet Fleurier S.A. from DKSH Holding AG (SWX:DKSH).Pascal Raffy agreed to acquire 25% stake in Bovet Fleurier S.A. from DKSH Holding AG (SWX:DKSH) on December 29, 2022. The transaction does not materially affect DKSH's profit and loss statement.공지 • Dec 16+ 1 more updateDKSH Holding AG to Report Fiscal Year 2022 Results on Feb 09, 2023DKSH Holding AG announced that they will report fiscal year 2022 results on Feb 09, 2023Buying Opportunity • Dec 07Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 3.3%. The fair value is estimated to be CHF87.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 7.3%. For the next 3 years, revenue is forecast to grow by 3.4% per annum. Earnings is also forecast to grow by 4.3% per annum over the same time period.Board Change • Nov 16Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Independent Chairman of the Board Marco Gadola was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Buying Opportunity • Nov 12Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 8.6%. The fair value is estimated to be CHF92.54, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 7.3%. Revenue is forecast to grow by 8.5% in 2 years. Earnings is forecast to grow by 2.7% in the next 2 years.공지 • Nov 08DKSH Holding AG (SWX:DKSH) signed an agreement to acquire Two pharma brands of Eisai.DKSH Holding AG (SWX:DKSH) signed an agreement to acquire Two pharma brands of Eisai on November 7, 2022.공지 • Nov 01DKSH Holding AG acquired 80% stake in Terra Firma.DKSH Holding AG agreed to acquire 80% stake in Terra Firma on September 22, 2022. The remainder stake will be held by Terra Firma's existing management team. Frank Gerhard, Jürg Frick and Eduard De Zordi of Homburger AG acted as legal advisor to DKSH Holding AG. BofA Securities acted as financial advisor to DKSH. DKSH Holding AG completed the acquisition of 80% stake in Terra Firma November 01, 2022.공지 • Sep 24DKSH Holding AG agreed to acquire Terra Firma.DKSH Holding AG agreed to acquire an 80% stake in Terra Firma on September 22, 2022. The remainder stake will be held by Terra Firma's existing management team. Frank Gerhard, Jürg Frick and Eduard De Zordi of Homburger AG acted as legal advisor to DKSH Holding AG.공지 • Jul 15DKSH Provides Earnings Guidance for the Year 2022DKSH provided earnings guidance for the year 2022. The company expects EBIT growth in 2022.공지 • Jun 28DKSH Holding AG (SWX:DKSH) agreed to acquire Refarmed Chemicals SA.DKSH Holding AG (SWX:DKSH) agreed to acquire Refarmed Chemicals SA on June 27, 2022. DKSH will acquire the business and will fully integrate the company into its existing operations. Frank Gerhard and Reto Heuberger of Homburger AG acted as legal advisor to DKSH Holding AG.공지 • Jun 01DKSH Holding AG (SWX:DKSH), entered into an agreement to acquire Acutest Systems (M) Sdn. Bhd.DKSH Holding AG (SWX:DKSH), entered into an agreement to acquire Acutest Systems (M) Sdn. Bhd., on May 31, 2022. Acutest Systems reported net sales of CHF 3 million in 2021. Acutest employees will join DKSH. The closing of the transaction is expected during the second quarter of 2022 and is subject to certain conditions.공지 • May 30DKSH Holding AG (SWX:DKSH) agreed to acquire DNIV Group.DKSH Holding AG (SWX:DKSH) agreed to acquire DNIV Group on May 30, 2022. DNIV Group has 110 employees and for the year ended 2021, DNIV Group has recorded sales of more than CHF 45 million. Transaction is subject to certain closing conditions and is expected to during the second quarter of 2022이익 및 매출 성장 예측SWX:DKSH - 애널리스트 향후 추정치 및 과거 재무 데이터 (CHF Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/202811,984270289384612/31/202711,595254274358712/31/202611,227236269348712/31/202511,090203282320N/A9/30/202511,140199281321N/A6/30/202511,190195280323N/A3/31/202511,149205301343N/A12/31/202411,109215321363N/A9/30/202411,006202320366N/A6/30/202410,903190319369N/A3/31/202410,996186330381N/A12/31/202311,089182341393N/A9/30/202311,223192343408N/A6/30/202311,357202344423N/A3/31/202311,348201291373N/A12/31/202211,339201237322N/A9/30/202211,290222267339N/A6/30/202211,242244297356N/A3/31/202211,183234318375N/A12/31/202111,123224338393N/A9/30/202111,019203343394N/A6/30/202110,915183348394N/A3/31/202110,836170319360N/A12/31/202010,757157290325N/A9/30/202011,028160274310N/A6/30/202011,299163257295N/A3/31/202011,439168250295N/A12/31/201911,579173242294N/A9/30/201911,437200N/A246N/A6/30/201911,294227N/A199N/A3/31/201911,329241N/A189N/A12/31/201811,363255N/A180N/A9/30/201811,386233N/A181N/A6/30/201811,408212N/A181N/A3/31/201811,214209N/A174N/A12/31/201711,019207N/A166N/A9/30/201710,869208N/A172N/A6/30/201710,719210N/A177N/A3/31/201710,612209N/A172N/A12/31/201610,505209N/A166N/A9/30/201610,336195N/A181N/A6/30/201610,166182N/A196N/A3/31/201610,108192N/A220N/A12/31/201510,051203N/A245N/A9/30/201510,110207N/A231N/A6/30/201510,169211N/A217N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: DKSH 의 연간 예상 수익 증가율(9.2%)이 saving rate(0.6%)보다 높습니다.수익 vs 시장: DKSH 의 연간 수익(9.2%)이 Swiss 시장(10.7%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: DKSH 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: DKSH 의 수익(연간 2.1%)이 Swiss 시장(연간 4.9%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: DKSH 의 수익(연간 2.1%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: DKSH의 자본 수익률은 3년 후 14.3%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YCapital-goods 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/12 22:16종가2026/05/12 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스DKSH Holding AG는 14명의 분석가가 다루고 있습니다. 이 중 7명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Chiara Di GiammariaBerenbergAndrew GroblerBNP ParibasNicholas de la GrenseBofA Global Research11명의 분석가 더 보기
Price Target Changed • Nov 21Price target decreased by 7.4% to CHF73.90Down from CHF79.80, the current price target is an average from 6 analysts. New target price is 31% above last closing price of CHF56.50. Stock is down 22% over the past year. The company is forecast to post earnings per share of CHF3.16 for next year compared to CHF3.09 last year.
Price Target Changed • May 12Price target decreased by 12% to CHF70.83Down from CHF80.83, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of CHF69.85. Stock is down 14% over the past year. The company is forecast to post earnings per share of CHF3.34 for next year compared to CHF3.09 last year.
공지 • Jul 15DKSH Provides Earnings Guidance for the Year 2022DKSH provided earnings guidance for the year 2022. The company expects EBIT growth in 2022.
공지 • Mar 30+ 1 more updateDKSH Holding AG Approves Board ElectionsDKSH Holding AG announced at annual general meeting held on March 27, 2026, the shareholders elected Corine Tap, and Julie von Wedel-Keller as new members of the Board of Directors.
Upcoming Dividend • Mar 24Upcoming dividend of CHF2.50 per shareEligible shareholders must have bought the stock before 31 March 2026. Payment date: 02 April 2026. Payout ratio is on the higher end at 80%, however this is supported by cash flows. Trailing yield: 4.3%. Within top quartile of Swiss dividend payers (3.6%). Higher than average of industry peers (2.6%).
공지 • Mar 23DKSH Holding AG(SWX:DKSH) dropped from FTSE All-World Index (USD)DKSH Holding AG(SWX:DKSH) dropped from FTSE All-World Index (USD)
공지 • Mar 06DKSH Holding AG, Annual General Meeting, Mar 27, 2026DKSH Holding AG, Annual General Meeting, Mar 27, 2026, at 10:00 W. Europe Standard Time.
Reported Earnings • Feb 19Full year 2025 earnings released: EPS: CHF3.12 (vs CHF3.31 in FY 2024)Full year 2025 results: EPS: CHF3.12 (down from CHF3.31 in FY 2024). Revenue: CHF11.1b (flat on FY 2024). Net income: CHF202.9m (down 5.5% from FY 2024). Profit margin: 1.8% (down from 1.9% in FY 2024). Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Trade Distributors industry in Europe. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
공지 • Feb 18DKSH Holding AG announces Annual dividend, payable on April 02, 2026DKSH Holding AG announced Annual dividend of CHF 2.5000 per share payable on April 02, 2026, ex-date on March 31, 2026 and record date on April 01, 2026.
내러티브 업데이트 • Feb 11DKSH: Potential Swixx Acquisition Will Support Undervalued Healthcare Distribution PlatformAnalysts have maintained their price target for DKSH Holding at around CHF 72.57. This suggests only very small adjustments in assumptions for the discount rate, long-term revenue growth, profit margin and future P/E to reflect updated risk and earnings expectations.
내러티브 업데이트 • Jan 27DKSH: Future Healthcare And Consumer Distribution Deals Will Support Undervalued SharesAnalysts have nudged their price target for DKSH Holding slightly higher, with fair value rising from CHF 72.17 to about CHF 72.57. This reflects small adjustments to assumptions around the discount rate, modestly stronger revenue growth, a marginally softer profit margin and a slightly higher future P/E multiple.
공지 • Jan 16DKSH Management AG Announces Retirement of Thomas Sul from the Role as Co-Head and Member of the Executive CommitteeDKSH Management AG announced that Thomas Sul, Co-Head of the Business Unit Performance Materials and Member of the Executive Committee, has decided to gradually scale down his activities as he eases into retirement and has stepped down from his role as Co-Head and Member of the Executive Committee. Natale Capri, who has served as Co-Head for over ten years, assumes full responsibility as Head of the Business Unit Performance Materials and will remain a Member of the Executive Committee. After nearly 30 years at DKSH, Thomas Sul leaves behind a remarkable legacy. Under his co-leadership, Performance Materials has achieved significant milestones, including driving globalization, strengthening business development, realizing multiple acquisitions, and doubling operating profit. Thomas will continue to contribute his expertise in a strategic capacity after scaling down his activities in the first quarter of 2026.
내러티브 업데이트 • Jan 12DKSH: Future Asia Distribution Deals Will Support Undervalued Share PriceAnalysts have trimmed their price target on DKSH Holding to about CHF 72, down from roughly CHF 74, citing updated assumptions for fair value, discount rate, revenue growth, profit margins and a slightly higher future P/E multiple. What's in the News DKSH is reported to be among potential bidders for Swiss pharmaceutical distributor Swixx Biopharma, with the target company said to be valued in a range of €1.5b to €2b.
공지 • Dec 19DKSH Holding AG (SWX:DKSH) agreed to acquire Biomedic Science Material Joint Stock Company.DKSH Holding AG (SWX:DKSH) agreed to acquire Biomedic Science Material Joint Stock Company on December 17, 2025. For the period ending December 31, 2024, Biomedic Science Material Joint Stock Company reported total revenue of CHF 12 million. The expected completion of the transaction is January 1, 2026 to March 31, 2026.
분석 기사 • Dec 15DKSH Holding (VTX:DKSH) Has More To Do To Multiply In Value Going ForwardIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
공지 • Nov 22DKSH Management Ltd. Announces Executive ChangesDKSH Management Ltd. announced the appointment of Patrik Grande as new Head Business Unit Healthcare as of January 2026. Currently Vice President, Commercial Outsourcing & Cluster Head APAC, he will be a member of DKSH's Executive Committee, report to CEO Stefan P. Butz, and will relocate from Bangkok to Singapore within the next year. Patrik Grande follows Bijay Singh who will begin his retirement on March 31, 2026, after eleven years at DKSH. Patrik Grande is a well-seasoned and accomplished leader with more than 20 years of experience in the global pharmaceutical industry. He joined DKSH in 2022 as Vice President, Business Unit Healthcare Thailand, following a successful two-decade career at Novartis. During his time at Novartis, he held increasingly senior leadership roles across multiple markets, including South Korea, Malaysia, the United Kingdom, Switzerland, Russia, and Spain. Since joining DKSH, Patrik has revitalized the Healthcare business in Thailand and delivered growth. In his role as Vice President, Commercial Outsourcing & Cluster Head APAC, he strengthened the strategic commercial outsourcing pillar, expanded the robust regional capabilities, delivering growth and driving strategic progress across the region. A Spanish citizen, Patrik holds a Master's degree in Business Administration from IESE Business School. Bijay Singh leaves behind an outstanding legacy after eleven years at DKSH, including nearly nine years as Head Business Unit Healthcare and Member of the Executive Committee. Bijay Singh joined DKSH as Vice President, Global Business Development for Business Unit Healthcare in 2015. His tenure was marked by significant achievements such as building robust commercial outsourcing capabilities, driving strategic M&As, expanding the Healthcare business into new markets such as Australia, the Philippines, and South Korea, and fostering a strong talent pipeline.
공지 • Nov 18DKSH Reportedly to Weigh Bid for Pharma Distributor Swixx BiopharmaDKSH Holding AG (SWX:DKSH) is among the companies exploring a potential acquisition of Swiss pharmaceutical distributor Swixx Biopharma (Swixx Biopharma SA), Bloomberg News reported on November 16, 2025, citing people familiar with the matter. Private-equity firms SK Capital Partners (SK Capital Partners, LP) and Lone Star (Lone Star Americas Acquisitions, Inc.) are also said to be evaluating bids. The sources indicated that Swixx could fetch EUR 1.5 billion to EUR 2 billion ($1.7 billion to $2.2 billion), though talks are ongoing and may not lead to a deal. Additional bidders could still join the process. Swixx, jointly owned by HBM Healthcare Investments and members of its management team, specializes in helping drugmakers navigate distribution in smaller and more regulated markets. The company operates in 44 countries and recorded EUR 900 million in 2023 revenue, according to its website. Zurich-based DKSH, valued at roughly CHF 3.5 billion, runs a similar distribution and marketing platform spanning healthcare, consumer goods, technology and industrial materials. Representatives for DKSH, Lone Star and HBM declined to comment to Bloomberg News. SK Capital did not respond to a request for comment, and Swixx could not be reached.
분석 기사 • Nov 16The Price Is Right For DKSH Holding AG (VTX:DKSH)With a median price-to-earnings (or "P/E") ratio of close to 20x in Switzerland, you could be forgiven for feeling...
내러티브 업데이트 • Sep 06Asia Pacific Expansion And Digitalization Will Fuel Sustainable SuccessThe consensus analyst price target for DKSH Holding has been revised downward, reflecting modest declines in both revenue growth forecasts and the future P/E ratio, resulting in a new fair value of CHF74.00. What's in the News DKSH Consumer Goods has partnered with Nextfood Global to launch premium breakfast cereals and freeze-dried fruit snacks in Singapore, targeting health-conscious, urban consumers.
분석 기사 • Aug 26DKSH Holding (VTX:DKSH) Hasn't Managed To Accelerate Its ReturnsDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...
분석 기사 • Aug 08DKSH Holding (VTX:DKSH) Seems To Use Debt Quite SensiblyThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Reported Earnings • Jul 20First half 2025 earnings: EPS misses analyst expectationsFirst half 2025 results: EPS: CHF1.41 (down from CHF1.71 in 1H 2024). Revenue: CHF5.53b (up 1.5% from 1H 2024). Net income: CHF91.8m (down 17% from 1H 2024). Profit margin: 1.7% (down from 2.0% in 1H 2024). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 18%. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Trade Distributors industry in Europe. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 9% per year.
공지 • Jun 20+ 1 more updateDKSH Holding AG to Report Fiscal Year 2025 Results on Feb 17, 2026DKSH Holding AG announced that they will report fiscal year 2025 results on Feb 17, 2026
분석 기사 • Jun 17Earnings Tell The Story For DKSH Holding AG (VTX:DKSH)It's not a stretch to say that DKSH Holding AG's ( VTX:DKSH ) price-to-earnings (or "P/E") ratio of 19.3x right now...
공지 • May 21DKSH Holding AG (SWX:DKSH) signed an agreement to acquire A.P.N Plastics Pty Ltd.DKSH Holding AG (SWX:DKSH) signed an agreement to acquire A.P.N Plastics Pty Ltd on May 20, 2025. DKSH will acquire the entire business and fully integrate the company into its existing operations. APN Plastics generates annual net sales of more than CHF 25 million. The transaction is subject to customary closing conditions. The closing of the transaction is expected during the second quarter of 2025.
분석 기사 • May 16DKSH Holding's (VTX:DKSH) Returns Have Hit A WallIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...
Valuation Update With 7 Day Price Move • Apr 04Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CHF58.70, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 15x in the Trade Distributors industry in Europe. Total loss to shareholders of 21% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CHF94.58 per share.
공지 • Mar 29DKSH Holding AG Announces Board ChangesDKSH Holding AG at its Annual General Meeting held on 27 March 2025, announced Dr. Hans Christoph Tanner did not stand for reelection. Suwannee Ratthayabandith was elected as a new member of the Board of Directors.
Upcoming Dividend • Mar 24Upcoming dividend of CHF2.35 per shareEligible shareholders must have bought the stock before 31 March 2025. Payment date: 02 April 2025. Payout ratio is a comfortable 71% and this is well supported by cash flows. Trailing yield: 3.2%. Lower than top quartile of Swiss dividend payers (4.0%). Higher than average of industry peers (2.4%).
공지 • Mar 07DKSH Holding AG to Report First Half, 2025 Results on Jul 17, 2025DKSH Holding AG announced that they will report first half, 2025 results on Jul 17, 2025
공지 • Feb 28DKSH Holding AG, Annual General Meeting, Mar 27, 2025DKSH Holding AG, Annual General Meeting, Mar 27, 2025, at 10:00 W. Europe Standard Time.
새 내러티브 • Feb 23New Partnerships With Alcon And Ichitan Will Expand Market Presence And Efficiency Strategic priorities and M&A partnerships are set to enhance market position and drive significant revenue and earnings growth.
Reported Earnings • Feb 13Full year 2024 earnings released: EPS: CHF3.31 (vs CHF2.80 in FY 2023)Full year 2024 results: EPS: CHF3.31 (up from CHF2.80 in FY 2023). Revenue: CHF11.1b (flat on FY 2023). Net income: CHF214.8m (up 18% from FY 2023). Profit margin: 1.9% (up from 1.6% in FY 2023). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Trade Distributors industry in Europe. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 1% per year.
공지 • Jan 07DKSH Holding AG (SWX:DKSH) acquired Clmo Technology Sdn. Bhd.DKSH Holding AG (SWX:DKSH) acquired Clmo Technology Sdn. Bhd. on January 7, 2025. Clmo Technology Sdn. Bhd.'s management team will join DKSH Holding AG’s business unit technology. DKSH Holding AG (SWX:DKSH) completed the acquisition of Clmo Technology Sdn. Bhd. on January 7, 2025.
공지 • Dec 06DKSH Holding AG to Report Fiscal Year 2024 Results on Feb 12, 2025DKSH Holding AG announced that they will report fiscal year 2024 results on Feb 12, 2025
공지 • Nov 13DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare DistributionDKSH Healthcare Business Unit, in partnership with Euris, is introducing ConnectPlus, a data-driven Customer Relationship Management (CRM) and Multi-Channel Engagement (MCE) platform aimed at transforming healthcare distribution across the Asia Pacific region. Designed to enhance productivity and operational efficiency, this platform provides a 360° view of healthcare professionals, streamlines MCE, and strengthens DKSH Healthcare's ability to tailor interactions and marketing strategies. The roll-out will start in Thailand in January 2025. With this new platform DKSH Healthcare reinforces its dedication to commercial excellence by enlarging possibilities and improving interactions with clients, customers, and patients. The introduction of ConnectPlus underscores DKSH Healthcare's commitment to harnessing digital solutions that orchestrate and maximize impact of both client and patient interactions, while upholding a high standard of operational excellence. ConnectPlus empowers DKSH to tap into the vast potential provided by the global healthcare big data market by delivering precise, targeted engagement strategies that cater to the unique needs of healthcare professionals, clients, and patients across the region. Furthermore, ConnectPlus is strategically designed to leverage the existing preference of face-to-face sales visits, by orchestrating personalized digital touchpoints, based on data driven insights, to prepare and enhance in-person interactions. The platform's ability to blend in-person and digital strategies is essential for maximizing outreach and driving meaningful engagement. By integrating advanced AI and analytics, ConnectPlus not only streamlines communication and marketing efforts but also personalizes interactions based on real-time data, ensuring relevance and impact. This marks a crucial milestone in DKSH Healthcare's journey towards fully integrating digital innovation into its operations, reinforcing its leadership in driving agility and efficiency within the rapidly evolving healthcare landscape.
Reported Earnings • Jul 18First half 2024 earnings released: EPS: CHF1.71 (vs CHF1.59 in 1H 2023)First half 2024 results: EPS: CHF1.71 (up from CHF1.59 in 1H 2023). Revenue: CHF5.45b (down 3.3% from 1H 2023). Net income: CHF111.2m (up 7.5% from 1H 2023). Profit margin: 2.0% (up from 1.8% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 3.9% p.a. on average during the next 3 years, compared to a 2.5% growth forecast for the Trade Distributors industry in Europe. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 4% per year.
Upcoming Dividend • Mar 21Upcoming dividend of CHF2.25 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 03 April 2024. Payout ratio is on the higher end at 80%, however this is supported by cash flows. Trailing yield: 3.6%. Lower than top quartile of Swiss dividend payers (4.1%). Higher than average of industry peers (2.2%).
Declared Dividend • Feb 29Dividend increased to CHF2.25Dividend of CHF2.25 is 4.7% higher than last year. Ex-date: 28th March 2024 Payment date: 3rd April 2024 Dividend yield will be 3.5%, which is higher than the industry average of 2.3%. Sustainability & Growth Dividend is covered by both earnings (80% earnings payout ratio) and cash flows (43% cash payout ratio). The dividend has increased by an average of 11% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 30% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Feb 18Full year 2023 earnings: EPS misses analyst expectationsFull year 2023 results: EPS: CHF2.80 (down from CHF3.10 in FY 2022). Revenue: CHF11.1b (down 2.2% from FY 2022). Net income: CHF182.0m (down 9.5% from FY 2022). Profit margin: 1.6% (down from 1.8% in FY 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 8.3%. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 2.8% growth forecast for the Trade Distributors industry in Europe. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has fallen by 2% per year.
공지 • Dec 23+ 2 more updatesDKSH Holding AG to Report First Half, 2024 Results on Jul 16, 2024DKSH Holding AG announced that they will report first half, 2024 results on Jul 16, 2024
Price Target Changed • Nov 21Price target decreased by 7.4% to CHF73.90Down from CHF79.80, the current price target is an average from 6 analysts. New target price is 31% above last closing price of CHF56.50. Stock is down 22% over the past year. The company is forecast to post earnings per share of CHF3.16 for next year compared to CHF3.09 last year.
공지 • Sep 19DKSH Holding AG (SWX:DKSH) agreed to acquire CS Company Ltd.DKSH Holding AG (SWX:DKSH) agreed to acquire CS Company Ltd on September 18, 2023. CS Company generates net sales of over CHF 35 million. The deal is expected to close in the fourth quarter, subject to certain conditions.
Reported Earnings • Jul 20First half 2023 earnings released: EPS: CHF1.59 (vs CHF1.58 in 1H 2022)First half 2023 results: EPS: CHF1.59 (up from CHF1.58 in 1H 2022). Revenue: CHF5.63b (flat on 1H 2022). Net income: CHF103.4m (flat on 1H 2022). Profit margin: 1.8% (in line with 1H 2022). Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Professional Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Buying Opportunity • Jun 22Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 8.1%. The fair value is estimated to be CHF83.15, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%. For the next 3 years, revenue is forecast to grow by 3.6% per annum. Earnings is also forecast to grow by 8.7% per annum over the same time period.
공지 • May 31DKSH Holding AG to Report First Half, 2023 Results on Jul 18, 2023DKSH Holding AG announced that they will report first half, 2023 results on Jul 18, 2023
Buying Opportunity • May 17Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 15%. The fair value is estimated to be CHF84.63, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%. For the next 3 years, revenue is forecast to grow by 3.6% per annum. Earnings is also forecast to grow by 8.7% per annum over the same time period.
Price Target Changed • May 12Price target decreased by 12% to CHF70.83Down from CHF80.83, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of CHF69.85. Stock is down 14% over the past year. The company is forecast to post earnings per share of CHF3.34 for next year compared to CHF3.09 last year.
공지 • May 11DKSH Appoints Chris Ritchie as New Head Business Unit Consumer GoodsDKSH announced the appointment of Chris Ritchie as new Head Business Unit Consumer Goods as of mid-August 2023. Based in Singapore, he will be a member of DKSH's Executive Committee and report to CEO Stefan P. Butz. Chris Ritchie follows Terry Seremetis, who, after four years, decided to pursue his career opportunities outside of DKSH as announced on January 3, 2023. Chris Ritchie has 28 years of experience in the consumer goods industry. For the last four years, he was Chief Global Business Officer of Sazerac, a leading privately held American spirit company, where he oversaw operations in Asia Pacific and Europe. From 2016 to 2019, he was General Manager at Reckitt Benckiser, responsible for the growth market Philippines. Prior to that, from 2007 to 2016, he held various General Manager and Director positions at SABMiller in Asia, Europe, and Americas, including Managing Director of SABMiller Vietnam. From 1995 to 2006, he held regional and global marketing roles at P&G. Throughout his career, Chris has driven growth, route-to-market, and built strong teams, especially in developing markets. A Canadian citizen,Chris (50 years) holds a Bachelor's degree in Economics from Queen's University in Kingston, Canada.
Buying Opportunity • Mar 18Now 21% undervaluedOver the last 90 days, the stock is up 3.3%. The fair value is estimated to be CHF92.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%. For the next 3 years, revenue is forecast to grow by 3.9% per annum. Earnings is also forecast to grow by 8.9% per annum over the same time period.
Upcoming Dividend • Mar 13Upcoming dividend of CHF2.15 per share at 2.8% yieldEligible shareholders must have bought the stock before 20 March 2023. Payment date: 22 March 2023. Payout ratio is a comfortable 69% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of Swiss dividend payers (4.2%). In line with average of industry peers (2.6%).
Buying Opportunity • Mar 01Now 20% undervaluedOver the last 90 days, the stock is up 7.8%. The fair value is estimated to be CHF95.74, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%. For the next 3 years, revenue is forecast to grow by 3.9% per annum. Earnings is also forecast to grow by 8.8% per annum over the same time period.
Buying Opportunity • Feb 10Now 19% undervaluedOver the last 90 days, the stock is up 14%. The fair value is estimated to be CHF98.76, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%. For the next 3 years, revenue is forecast to grow by 4.1% per annum. Earnings is also forecast to grow by 8.7% per annum over the same time period.
Reported Earnings • Feb 10Full year 2022 earnings released: EPS: CHF3.09 (vs CHF3.45 in FY 2021)Full year 2022 results: EPS: CHF3.09 (down from CHF3.45 in FY 2021). Revenue: CHF11.4b (up 2.1% from FY 2021). Net income: CHF201.1m (down 10% from FY 2021). Profit margin: 1.8% (down from 2.0% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Professional Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 10% per year.
공지 • Dec 31Pascal Raffy agreed to acquire 25% stake in Bovet Fleurier S.A. from DKSH Holding AG (SWX:DKSH).Pascal Raffy agreed to acquire 25% stake in Bovet Fleurier S.A. from DKSH Holding AG (SWX:DKSH) on December 29, 2022. The transaction does not materially affect DKSH's profit and loss statement.
공지 • Dec 16+ 1 more updateDKSH Holding AG to Report Fiscal Year 2022 Results on Feb 09, 2023DKSH Holding AG announced that they will report fiscal year 2022 results on Feb 09, 2023
Buying Opportunity • Dec 07Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 3.3%. The fair value is estimated to be CHF87.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 7.3%. For the next 3 years, revenue is forecast to grow by 3.4% per annum. Earnings is also forecast to grow by 4.3% per annum over the same time period.
Board Change • Nov 16Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Independent Chairman of the Board Marco Gadola was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Buying Opportunity • Nov 12Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 8.6%. The fair value is estimated to be CHF92.54, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 7.3%. Revenue is forecast to grow by 8.5% in 2 years. Earnings is forecast to grow by 2.7% in the next 2 years.
공지 • Nov 08DKSH Holding AG (SWX:DKSH) signed an agreement to acquire Two pharma brands of Eisai.DKSH Holding AG (SWX:DKSH) signed an agreement to acquire Two pharma brands of Eisai on November 7, 2022.
공지 • Nov 01DKSH Holding AG acquired 80% stake in Terra Firma.DKSH Holding AG agreed to acquire 80% stake in Terra Firma on September 22, 2022. The remainder stake will be held by Terra Firma's existing management team. Frank Gerhard, Jürg Frick and Eduard De Zordi of Homburger AG acted as legal advisor to DKSH Holding AG. BofA Securities acted as financial advisor to DKSH. DKSH Holding AG completed the acquisition of 80% stake in Terra Firma November 01, 2022.
공지 • Sep 24DKSH Holding AG agreed to acquire Terra Firma.DKSH Holding AG agreed to acquire an 80% stake in Terra Firma on September 22, 2022. The remainder stake will be held by Terra Firma's existing management team. Frank Gerhard, Jürg Frick and Eduard De Zordi of Homburger AG acted as legal advisor to DKSH Holding AG.
공지 • Jul 15DKSH Provides Earnings Guidance for the Year 2022DKSH provided earnings guidance for the year 2022. The company expects EBIT growth in 2022.
공지 • Jun 28DKSH Holding AG (SWX:DKSH) agreed to acquire Refarmed Chemicals SA.DKSH Holding AG (SWX:DKSH) agreed to acquire Refarmed Chemicals SA on June 27, 2022. DKSH will acquire the business and will fully integrate the company into its existing operations. Frank Gerhard and Reto Heuberger of Homburger AG acted as legal advisor to DKSH Holding AG.
공지 • Jun 01DKSH Holding AG (SWX:DKSH), entered into an agreement to acquire Acutest Systems (M) Sdn. Bhd.DKSH Holding AG (SWX:DKSH), entered into an agreement to acquire Acutest Systems (M) Sdn. Bhd., on May 31, 2022. Acutest Systems reported net sales of CHF 3 million in 2021. Acutest employees will join DKSH. The closing of the transaction is expected during the second quarter of 2022 and is subject to certain conditions.
공지 • May 30DKSH Holding AG (SWX:DKSH) agreed to acquire DNIV Group.DKSH Holding AG (SWX:DKSH) agreed to acquire DNIV Group on May 30, 2022. DNIV Group has 110 employees and for the year ended 2021, DNIV Group has recorded sales of more than CHF 45 million. Transaction is subject to certain closing conditions and is expected to during the second quarter of 2022
